eDruginfo.com - raloxifene

Drug Updates | New Indications

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

News Capsules

Drug Warnings

Herbal Spotlight

Quik Tools

Drug Info Links

Drug Info Bookstore

Feedback

Registration

Disclaimer

raloxifene
Evista	Pharmaceutical company: Eli Lilly and Company www.lilly.com

NEW INDICATION & DOSAGE
Reduction of the risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast cancer--
Adults: 60 mg P.O. daily.

Home - Guest Registry - Customer Service